Boston Common Asset Management LLC lessened its stake in Aetna Inc. (NYSE:AET) by 9.0% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,130 shares of the company’s stock after selling 900 shares during the quarter. Boston Common Asset Management LLC’s holdings in Aetna were worth $1,386,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. State of Tennessee Treasury Department increased its holdings in shares of Aetna by 26.3% during the 2nd quarter. State of Tennessee Treasury Department now owns 557,814 shares of the company’s stock worth $84,692,000 after buying an additional 116,280 shares during the last quarter. Pictet & Cie Europe SA purchased a new position in shares of Aetna in the 2nd quarter worth $2,269,000. Banque Pictet & Cie SA purchased a new position in shares of Aetna in the 2nd quarter worth $10,567,000. NBT Bank N A NY purchased a new position in shares of Aetna in the 2nd quarter worth $215,000. Finally, Cambridge Investment Research Advisors Inc. raised its position in shares of Aetna by 4.5% in the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 36,731 shares of the company’s stock worth $5,577,000 after buying an additional 1,590 shares during the period. Institutional investors own 89.52% of the company’s stock.

Aetna Inc. (NYSE:AET) traded up 0.513% during midday trading on Monday, reaching $159.825. The company’s stock had a trading volume of 404,686 shares. The firm has a market capitalization of $53.08 billion, a PE ratio of 35.477 and a beta of 0.53. Aetna Inc. has a 52 week low of $104.59 and a 52 week high of $164.52. The stock has a 50 day moving average of $157.50 and a 200 day moving average of $145.70.

Aetna (NYSE:AET) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, topping the consensus estimate of $2.34 by $1.08. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The business had revenue of $15.52 billion during the quarter, compared to analysts’ expectations of $15.34 billion. During the same quarter in the previous year, the firm earned $2.21 EPS. The firm’s revenue was down 2.7% compared to the same quarter last year. On average, equities research analysts predict that Aetna Inc. will post $9.55 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Thursday, October 12th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.26%. The ex-dividend date of this dividend is Wednesday, October 11th. Aetna’s dividend payout ratio (DPR) is currently 43.67%.

ILLEGAL ACTIVITY WARNING: “Aetna Inc. (AET) Shares Sold by Boston Common Asset Management LLC” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://www.watchlistnews.com/aetna-inc-aet-shares-sold-by-boston-common-asset-management-llc/1603365.html.

In other news, EVP Margaret M. Mccarthy sold 10,288 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the completion of the transaction, the executive vice president now directly owns 33,563 shares in the company, valued at $5,465,734.55. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, President Karen S. Lynch sold 15,271 shares of the company’s stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $161.91, for a total value of $2,472,527.61. Following the transaction, the president now owns 64,261 shares of the company’s stock, valued at $10,404,498.51. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

A number of research analysts recently weighed in on AET shares. Morgan Stanley began coverage on Aetna in a report on Tuesday, June 6th. They issued an “overweight” rating and a $162.00 target price on the stock. Royal Bank Of Canada upped their price target on Aetna from $147.00 to $162.00 and gave the stock an “outperform” rating in a research note on Friday, June 9th. Citigroup Inc. assumed coverage on Aetna in a report on Wednesday, June 28th. They issued a “buy” rating and a $180.00 price objective on the stock. Zacks Investment Research upgraded Aetna from a “hold” rating to a “buy” rating and set a $170.00 price objective on the stock in a report on Tuesday, July 4th. Finally, Credit Suisse Group reaffirmed an “outperform” rating and issued a $165.00 price objective (up from $160.00) on shares of Aetna in a research note on Thursday, July 13th. Seven research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. The company has an average rating of “Buy” and an average price target of $160.77.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.